melbourne do drugs could battle maturate help people live years may available inside next five years new landmark research suggests study proves single enzyme body targeted potential preclude diseases extend lifespans research put out journal science shows drugs tested work single enzyme common mechanism means whole new class drugs viable could ultimately prevent cancer alzheimer disease type diabetes ultimately drugs would treat 1 disease unlike drugs today would prevent others says lead author paper prof david sinclair university new south wale unsw medicine effect would slow aging said target enzyme switched naturally calorie restriction exercise also enhanced activators common activator resveratrol found small quantities red wine synthetic activators much warm activity already developed animal models overweight mouse precondition synthetic substance resveratrol able run double far slim mice lived per cent longer looking whether benefits already healthy things also looking promising sinclair said statement finding aging irreversible affliction thought usa could live wo get without research said history pharmaceuticals never drug tweaks enzyme make run faster said sinclair technology sold pharmaceutical giant glaxosmithkline quatern thousand synthetic activators times potent single glass red wine educate best three human trials drugs mimic benefits diet exercise impact weight sound out sinclair suggests first therapeutic marketed diabetes confine trials people type diabetes skin incitive disease psoriasis benefits metamorphosis first group reduction skin redness second drugs administered orally topically drug would strictly prescribed certain conditions sinclair suggests matchless day could taken orally preventative